A National Centre for Precision Medicine on the theme of diabetes for the Hauts-de-France
On Wednesday, October 15, the State approved an allocation of 5 million for the financing of the National Centre for Precision Diabetes Medicine (PreciDIAB).
Supported since the beginning by all the members of the I-site Université Lille Nord-Europe and led by Professor Philippe Froguel, renowned researcher and current director of the European Institute of Diabetes Genomics (EGID), this project aims to make the Lille site a world-class research centre for the treatment and prevention of obesity and diabetes, for the benefit of the Hauts-de-France thanks to the development of collaborations between the Amiens University Hospital and the Lille University Hospital. In addition to the State allocation, this project mobilises more than €15 million in grants from the European Metropolitan Area of Lille (€11 million) voted last Friday, Amiens Metropolitan Area (€1 million), the Regional Council and the ERDF (€4 million) in addition to the €51 million in equity funding provided by the University Hospital and the University of Lille.
Inria brings to the National Precision Center of Diabetes Medicine its expertise in digital sciences, including artificial intelligence, data science, Internet of Things, and human-machine interaction.
These articles could interest you:
The I-site1 is:
- 4 founding members
- 190 companies involved
- 15 million euros in specific annual funding
- 74000 students
- 2100 doctoral students
- 720 patents
- 4 laboratories of excellence and 6 equipment of excellence